|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/30 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Number of the document | 3321286 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17206703.5 |
| Date of filing the European patent application | 2012-08-21 | |
| (97) | Date of publication of the European application | 2018-05-16 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 11178370 | 2011-08-23 | EP | |
| 12168192 | 2012-05-16 | EP |
| (72) |
AST, Oliver, CH
BRUENKER, Peter, CH
FAUTI, Tanja, CH
FREIMOSER-GRUNDSCHOBER, Anne, CH
NEUMANN, Christiane, CH
KLEIN, Christian, CH
MOESSNER, Ekkehard, CH
UMANA, Pablo, CH
|
| (73) |
Roche Glycart AG,
Wagistrasse 10, 8952 Schlieren,
CH
|
| (54) | BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES |
| BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES |